Chapter 36. Diabetic Retinopathy

  1. Richard I. G. Holt MA, MB BChir, PhD, FRCP, FHEA Professor in Diabetes & Endocrinology3,
  2. Clive S. Cockram MB BS, BSc, MD (Lond), FRCP, FRACP, FHKAM (Med) Emeritus Professor of Medicine4,
  3. Allan Flyvbjerg MD, DMSc Professor of Clinical Endocrinology Chair5 and
  4. Barry J. Goldstein MD, PhD, FACP, FACE Therapeutic Area Head Vice President6
  1. Peter H. Scanlon MD, MRCOphth, DCH, FRCP Lecturer1,2

Published Online: 9 JUL 2010

DOI: 10.1002/9781444324808.ch36

Textbook of Diabetes, Fourth Edition

Textbook of Diabetes, Fourth Edition

How to Cite

Scanlon, P. H. (2010) Diabetic Retinopathy, in Textbook of Diabetes, Fourth Edition (eds R. I. G. Holt, C. S. Cockram, A. Flyvbjerg and B. J. Goldstein), Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781444324808.ch36

Editor Information

  1. 3

    Developmental Origins of Health and Disease Division, University of Southampton School of Medicine, Southampton, UK

  2. 4

    Chinese University of Hong Kong, Hong Kong SAR, People's Republic of China

  3. 5

    Department of Endocrinology and Internal Medicine, The Medical Research Laboratories, Aarhus University Hospital – Aarhus University, Aarhus, Denmark

  4. 6

    Clinical Research, Metabolism Merck Research Laboratories Rahway, NJ, USA

Author Information

  1. 1

    Gloucestershire and Oxford Eye Units, University of Oxford, Oxford, UK

  2. 2

    Harris Manchester College, University of Oxford, Oxford, UK

Publication History

  1. Published Online: 9 JUL 2010
  2. Published Print: 9 JUL 2010

ISBN Information

Print ISBN: 9781405191814

Online ISBN: 9781444324808

Keywords:

  • Risk factors for diabetic retinopathy;
  • Pathophysiologic events in diabetic retinopathy;
  • Investigative techniques to assess diabetic retinopathy;
  • Mechanisms of action of laser for macular edema;
  • Adverse effects of macular laser treatment;
  • Moderate and severe non - proliferative diabetic retinopathy (ETDRS & International) and pre - proliferative diabetic retinopathy (English Screening);
  • Proliferative diabetic retinopathy and advanced diabetic retinopathy;
  • Factors other than high risk characteristics influencing the decision to laser;
  • Stage R3 with M1: proliferative diabetic retinopathy with maculopathy;
  • Use of intravitreal vascular endothelial growth factor inhibitors

Summary

This chapter contains sections titled:

  • Introduction - a historical perspective

  • The normal eye

  • Risk factors for diabetic retinopathy

  • Pathophysiologic events in diabetic retinopathy

  • The consultation

  • Screening for diabetic retinopathy

  • Lesions and classifications of diabetic retinopathy

  • Maculopathy

  • Mild non - proliferative diabetic retinopathy (ETDRS & International) and background diabetic retinopathy (English Screening)

  • Moderate and severe non - proliferative diabetic retinopathy (ETDRS & International) and pre - proliferative diabetic retinopathy (English Screening)

  • Proliferative diabetic retinopathy and advanced diabetic retinopathy

  • Stage R3 with M1: proliferative diabetic retinopathy with maculopathy

  • Use of intravitreal vascular endothelial growth factor inhibitors

  • Vitrectomy

  • Pregnancy and the diabetic eye

  • Low vision and blindness from diabetic retinopathy

  • References